| Zacks Investment Research Analysts Reiterate a Outperform Rating on Alexion ... - LocalizedUSA |
|
|
LocalizedUSA ... development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hematology, nephrology (including transplant rejection), neurology, |